Incredible for SE1 to move into this space, especially along side Harvard.
Animal testing or petri dish testing has always had its flaws to mimic the human body. Organ-on-a-chip moulds made by SE1 help solve this problem moving forward.
The likes of Abiomed, Harvard and Smartbow/Zoetis in the books of SE1....does not sound like a 28m mcap stock to me.